Active Biotech AB (ACTI) — Cash Flow-to-Debt Ratio
Active Biotech AB (ACTI) has a Cash Flow-to-Debt Ratio of -0.58x as of September 2025, meaning its operating cash flow of Skr-7.20 Million could theoretically repay -1% of its total liabilities (Skr12.50 Million) in one year. Check ACTI cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Active Biotech AB Cash Flow-to-Debt Ratio (2002–2024)
Historical debt coverage capacity for Active Biotech AB across 23 annual periods. Also explore Active Biotech AB (ACTI) total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Active Biotech AB (2002–2024)
Year-by-year debt coverage analysis for Active Biotech AB. For market capitalisation and broader financial context, see market value of Active Biotech AB.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -3.63x | Skr-40.40 Million | Skr11.13 Million | ▼ -6.2% |
| 2023 | -3.42x | Skr-45.74 Million | Skr13.38 Million | ▼ -2.8% |
| 2022 | -3.33x | Skr-54.85 Million | Skr16.49 Million | ▲ +27.0% |
| 2021 | -4.56x | Skr-46.17 Million | Skr10.13 Million | ▼ -42.1% |
| 2020 | -3.21x | Skr-32.22 Million | Skr10.04 Million | ▼ -18.0% |
| 2019 | -2.72x | Skr-35.81 Million | Skr13.17 Million | ▼ -1335.0% |
| 2018 | -0.19x | Skr-40.65 Million | Skr214.52 Million | ▲ +7.7% |
| 2017 | -0.21x | Skr-46.45 Million | Skr226.14 Million | ▲ +35.3% |
| 2016 | -0.32x | Skr-73.16 Million | Skr230.32 Million | ▲ +60.8% |
| 2015 | -0.81x | Skr-217.89 Million | Skr268.84 Million | ▲ +3.7% |
| 2014 | -0.84x | Skr-267.09 Million | Skr317.21 Million | ▼ -198.4% |
| 2013 | -0.28x | Skr-102.25 Million | Skr362.40 Million | ▲ +58.1% |
| 2012 | -0.67x | Skr-240.40 Million | Skr356.82 Million | ▼ -411.4% |
| 2011 | -0.13x | Skr-46.97 Million | Skr356.53 Million | ▲ +78.4% |
| 2010 | -0.61x | Skr-196.32 Million | Skr321.34 Million | ▲ +15.8% |
| 2009 | -0.73x | Skr-224.77 Million | Skr309.86 Million | ▼ -40.7% |
| 2008 | -0.52x | Skr-159.46 Million | Skr309.34 Million | ▲ +17.2% |
| 2007 | -0.62x | Skr-186.70 Million | Skr299.97 Million | ▼ -149.9% |
| 2006 | -0.25x | Skr-100.13 Million | Skr402.04 Million | ▲ +49.4% |
| 2005 | -0.49x | Skr-192.51 Million | Skr391.05 Million | ▲ +50.5% |
| 2004 | -0.99x | Skr-149.65 Million | Skr150.59 Million | ▲ +80.8% |
| 2003 | -5.17x | Skr-288.83 Million | Skr55.82 Million | ▼ -54.7% |
| 2002 | -3.34x | Skr-291.71 Million | Skr87.24 Million | — |